Latest accounts payable for HSDT: $2M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Helius Medical Technologies (HSDT) currently reports a accounts payable of $2M as of March 2026. That compares with $1.2M in the prior-year period — up 62.7% year over year. Use the charts on this page to explore Helius Medical Technologies's accounts payable history and peer comparisons.
Helius Medical Technologies's accounts payable increased from $1.2M to $2M — a 62.7% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Helius Medical Technologies reported $2M in accounts payable as of March 2026. That compares with $1.2M in the prior-year period — up 62.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current accounts payable of $2M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Helius Medical Technologies, and consider following HSDT for alerts when major investors trade the stock.
Helius Medical Technologies is classified in the Technology sector. On accounts payable, it currently shows $2M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing HSDT with unrelated industries.